Meridian Bioscience Inc
VIVO
VIVO was delisted on the 30th of January, 2023.
180 hedge funds and large institutions have $744M invested in Meridian Bioscience Inc in 2016 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 72 increasing their positions, 43 reducing their positions, and 14 closing their positions.
79% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 14
67% more repeat investments, than reductions
Existing positions increased: 72 | Existing positions reduced: 43
5% more funds holding
Funds holding: 172 → 180 (+8)
7% less capital invested
Capital invested by funds: $802M → $744M (-$57.4M)
37% less call options, than puts
Call options by funds: $1.2M | Put options by funds: $1.89M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$3.47M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.37M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$2.63M |
| 4 |
Norges Bank
Oslo,
Norway
|
+$2.32M |
| 5 |
AI
Analytic Investors
Los Angeles,
California
|
+$1.91M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Schroder Investment Management Group
London,
United Kingdom
|
-$19.3M |
| 2 |
Neuberger Berman Group
New York
|
-$16.3M |
| 3 |
MCM
McKinley Capital Management
Anchorage,
Alaska
|
-$6.82M |
| 4 |
PCM
Piermont Capital Management
St. Louis,
Missouri
|
-$2.45M |
| 5 |
Fifth Third Bancorp
Cincinnati,
Ohio
|
-$1.9M |
VIVO Hedge Fund Activity: Q2 2016 in Review
180 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Meridian Bioscience Inc (VIVO) for Q2 2016, worth a combined $744M — down 7.2% from $802M a quarter earlier.
Buyers outnumbered sellers: 25 funds opened new VIVO positions and 14 closed out — a net gain of 11 holders — while 72 added to existing stakes and 43 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $3.47M. The largest seller was Schroder Investment Management Group, cutting an estimated $19.3M.
- 180 institutional investors held Meridian Bioscience Inc (VIVO) as of Q2 2016, up from 172 in Q1 2016.
- Funds reported $744M of Meridian Bioscience Inc stock for Q2 2016, down 7.2% quarter-over-quarter.
- 25 funds opened new Meridian Bioscience Inc positions in Q2 2016 and 14 closed out, a net change of +11 holders.
- The largest Meridian Bioscience Inc buyer in Q2 2016 was Morgan Stanley, an estimated $3.47M added.
- The largest Meridian Bioscience Inc seller in Q2 2016 was Schroder Investment Management Group, an estimated $19.3M sold.
Based on aggregated 13F filings for Q2 2016.